Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed2
Recruiting2
Terminated1

Role Distribution

Principal Investigator1
Other Roles4
PI Rate20%

Activity Timeline

Clinical Trials (5)

NCT06514898Phase 1Recruiting
Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
StudychairStart date: 2025-05-05
NCT06254326Phase 1Recruiting
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Progressive OligodendrogliomaRecurrent Oligodendroglioma
StudychairStart date: 2024-09-19
NCT03334305Phase 1Terminated
Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
High Grade GliomaMalignant Glioma
StudychairStart date: 2018-08-27
NCT02465268Phase 2Completed
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
Astrocytoma, Grade IVGBMGlioblastoma+2 more
StudychairStart date: 2016-08-09
NCT01326104Phase 2Completed
Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
MedulloblastomaNeuroectodermal Tumor
PrincipalinvestigatorStart date: 2010-09-07

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maryam Rahman, MD

University of Florida

Moderately Similar
4 trials

Shared therapeutic areas:

GlioblastomaGBMGlioblastoma Multiforme+1 more

Worked with same sponsors:

National Cancer Institute (NCI)University of Florida
Collaborated on 1 trial
Similarity Score44%

Ashley Ghiaseddin, MD

University of Florida

Moderately Similar
6 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma MultiformeProgressive Oligodendroglioma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)Oligo Nation, Inc+1 more
Collaborated on 1 trial
Similarity Score44%

John Ligon, MD

University of Florida

Moderately Similar
4 trials

Shared therapeutic areas:

GlioblastomaRecurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma

Worked with same sponsors:

Children's National Research InstituteNational Cancer Institute (NCI)+2 more
Collaborated on 1 trial
Similarity Score34%

Elias Sayour, MD, PhD

University of Florida

Related
5 trials

Shared therapeutic areas:

High Grade GliomaMalignant Glioma

Worked with same sponsors:

Moffitt Clinical Research Network (MCRN)National Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

High Grade GliomaGlioblastomaGlioblastoma Multiforme+1 more
Similarity Score11%

Sean Grimm, MD

Northwestern University

Related
2 trials

Shared therapeutic areas:

GBMGlioblastoma MultiformeMalignant Glioma
Similarity Score8%

Steven Chmura, MD

University of Chicago

Related
5 trials

Shared therapeutic areas:

GBMGlioblastoma MultiformeMalignant Glioma
Similarity Score8%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Malignant GliomaGBMGlioblastoma Multiforme

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Adam Mamelak, MD

Cedars-Sinai Medical Center

Related
6 trials

Shared therapeutic areas:

GBMGlioblastoma MultiformeMalignant Glioma
Similarity Score8%

Katherine E Warren, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Glioblastoma MultiformeMalignant GliomaMedulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06514898Phase 1StudyChair

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
Recruiting
NCT06254326Phase 1StudyChair

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

Progressive OligodendrogliomaRecurrent Oligodendroglioma
Recruiting
NCT03334305Phase 1StudyChair

Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas

High Grade GliomaMalignant Glioma
Terminated
NCT02465268Phase 2StudyChair

Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

Astrocytoma, Grade IVGBMGlioblastoma+2 more
Completed
NCT01326104Phase 2PrincipalInvestigator

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

MedulloblastomaNeuroectodermal Tumor
Completed

All 5 trials loaded